Syntheses and biological activities of new N-1-aryl substituted quinolone antibacterials

被引:17
作者
Jurgens, J
Schedletzky, H
Heisig, P
Seydel, JK
Wiedemann, B
Holzgrabe, U
机构
[1] PHARMACEUT MICROBIOL,D-53115 BONN,GERMANY
[2] INST BIOL & MED EXPTL,D-23845 BORSTEL,GERMANY
关键词
N-1-aryl substituted quinolones; MIC; DNA gyrase inhibition; QSAR; GYRASE-A-PROTEIN; COLI DNA GYRASE; ESCHERICHIA-COLI; RESISTANT MUTATIONS; NALIDIXIC-ACID; POINT MUTATION; GENE; AGENTS; FLUOROQUINOLONES; INHIBITION;
D O I
10.1002/ardp.19963290403
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of quinolones with a systematically varied substitution at the phenyl ring at N1 has been synthesized. Three lipophilicity descriptors (log K, log P, R(m)) and the pK(a) values have been determined as well as the microbiological activity. The MIC values for eight different strains of three Gram-positive and three of DNA supercoiling (IC90 and IC100) were determined. From a principal component and a QSAR analysis relationships between the antibacterial activity concerning the whole-cell system and electronic properties as well as the length of the substituents at the phenyl rings could be derived. The activity in a cell-free system was governed by the lipophilicity and width of the substituents. It is speculated that the quinolones take a defined place in the DNA gyrase-DNA complex which is characterized by polar amino acids. This is in agreement with findings from studies of mutant gyrases.
引用
收藏
页码:179 / 190
页数:12
相关论文
共 38 条
[1]  
[Anonymous], 1984, CHEMOMETRICS MATH ST
[2]   RELATIONSHIPS AMONG ANTIBACTERIAL ACTIVITY, INHIBITION OF DNA GYRASE, AND INTRACELLULAR ACCUMULATION OF 11-FLUOROQUINOLONES [J].
BAZILE, S ;
MOREAU, N ;
BOUZARD, D ;
ESSIZ, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (12) :2622-2627
[3]  
BONELLI D, 1993, PHARM PHARM LETT, V3, P13
[4]   STRUCTURE ACTIVITY RELATIONSHIP IN A SERIES OF QUINOLONES [J].
CALAS, M ;
BOMPART, J ;
GIRAL, L ;
GRASSY, G .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1991, 26 (03) :279-290
[5]   NOVEL GYRA POINT MUTATION IN A STRAIN OF ESCHERICHIA-COLI RESISTANT TO FLUOROQUINOLONES BUT NOT TO NALIDIXIC-ACID [J].
CAMBAU, E ;
BORDON, F ;
COLLATZ, E ;
GUTMANN, L .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (06) :1247-1252
[6]  
Chu D. T. W., 1991, Adv. Drug Res., V21, P39
[7]   SYNTHESIS AND STRUCTURE ACTIVITY RELATIONSHIPS OF NOVEL ARYLFLUOROQUINOLONE ANTIBACTERIAL AGENTS [J].
CHU, DTW ;
FERNANDES, PB ;
CLAIBORNE, AK ;
PIHULEAC, E ;
NORDEEN, CW ;
MALECZKA, RE ;
PERNET, AG .
JOURNAL OF MEDICINAL CHEMISTRY, 1985, 28 (11) :1558-1564
[9]   CLONING AND CHARACTERIZATION OF A DNA GYRASE-A GENE FROM ESCHERICHIA-COLI THAT CONFERS CLINICAL RESISTANCE TO 4-QUINOLONES [J].
CULLEN, ME ;
WYKE, AW ;
KURODA, R ;
FISHER, LM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (06) :886-894
[10]   NEW STRUCTURE-ACTIVITY-RELATIONSHIPS OF THE QUINOLONE ANTIBACTERIALS USING THE TARGET ENZYME - THE DEVELOPMENT AND APPLICATION OF A DNA GYRASE ASSAY [J].
DOMAGALA, JM ;
HANNA, LD ;
HEIFETZ, CL ;
HUTT, MP ;
MICH, TF ;
SANCHEZ, JP ;
SOLOMON, M .
JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (03) :394-404